Eric Topol's Top 10 Tech Advances of 2015


December 15, 2015

Fetal sequencing, noninvasive prenatal testing, and familial cancer sequencing. Already, more than 800,000 noninvasive prenatal tests have been done using a single tube of blood at approximately 10 weeks of pregnancy for fetal DNA low-pass sequencing.[5] This has resulted in more than 70% reduction in the need for amniocentesis across the United States. Similarly, after the Myriad Genetics Supreme Court decision, a number of companies are offering not only BRCA gene sequencing for considerably lower cost. Such companies as Color Genomics offer sequencing of 19 oncogenes for $250, and Counsyl sequences 22 genes for $349.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.